J&J Nicorette Survey: COVID-19 Drives A Quarter Of UK Smokers To Want To Quit

Research shows more and more UK consumers wanting to quit in the wake of the pandemic. J&J Consumer Health is looking to pharmacy as well as its new Nicorette QuickMist SmartTrack product to support smokers on their post-COVID quitting journey. 

• Source: Shutterstock

New research by Johnson & Johnson Consumer Health has found that more than half of smokers in Europe, the Middle East and Africa say they want to be both tobacco and nicotine free.

In the UK, J&J’s survey of 1,113 Brits aged 16 to 75 years old found that over a quarter of these smokers interested in smoking cessation cited

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United Kingdom

Value Of Consumer Wearables Within The Clinic Currently Unknown, Says Cardiologist

 

“It’s quite likely [consumer wearable manufacturers] are changing the sensitivity and specificity based on consumer feedback, but not for medical reasons,” said Dipak Kotecha, a University of Birmingham professor of cardiology. Often, self-reported performance evidence from manufacturers is “low quality and biased.”

Over The Counter: Brands, Brexit And New Self-Care Business Models, With PAGB’s Michelle Riddalls

 
• By 

HBW Insight catches up with UK OTC industry association CEO Michelle Riddalls to talk about digital self-care and the unrealized promise of Brexit - part 2.

Clasado Divests Bimuno Prebiotic Consumer Brand To UK’s Eleat

 
• By 

Eleat's acquisition encompasses Clasado's Bimuno finished supplement product line and customer base, but not its Bimuno GOS proprietary galactooligosaccharide prebiotic ingredient.

‘The Only Certainty Is Uncertainty’ In The UK’s Consumer Health Market

 
• By 

While uncertainty might reign in the UK consumer health market - which grew by by 8% to £4.1bn ($5.3bn) in 2024 - “opportunity is everywhere” according to NielsenIQ health and beauty insights manager Alex Heffernan.

More from Europe

OTCs Are ‘Beacon Of Hope’ For Austrian Pharmacy

 
• By 

Just under half of Austrian pharmacists surveyed by Elpato Medien are “convinced that the OTC business will ensure the survival of their pharmacy.”

Over The Counter: Brands, Brexit And New Self-Care Business Models, With PAGB’s Michelle Riddalls

 
• By 

HBW Insight catches up with UK OTC industry association CEO Michelle Riddalls to talk about digital self-care and the unrealized promise of Brexit - part 2.

Plenty For Industry To Do As EU Wastewater Directive Faces Legal Challenges

 
• By 

Engaging with EU member state legislators, stressing the impact of national EPR systems on the accessibility, availability, and affordability of medicines, reformulating products to reduce their financial contribution, and lobbying for expanding the scope of EPR schemes to include other polluting industries are all ways that the European consumer health industry can try and influence the way that the revised Urban Wastewater Treatment Directive is transposed into national legislation, law firm Mason Hayes & Curran explains.